Related Experiment Video
Updated: Dec 29, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis
Sonu Kashyap1, Kyaw Zaw Hein1, Claudia Cs Chini1
1Department of Anesthesiology and Robert and Arlene Kogod Center on Aging.
Insights
Autosomal dominant polycystic kidney disease (ADPKD) involves increased Pregnancy-associated plasma protein A (PAPP-A), which drives cyst growth. Inhibiting PAPP-A activity offers a potential new therapy for ADPKD.
Area of Science:
- Nephrology
- Genetics
- Molecular Biology
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is a leading genetic cause of end-stage renal disease (ESRD) with limited treatment options.
- IGF-1 pathway gene upregulation was observed in ADPKD mouse models.
- Pregnancy-associated plasma protein A (PAPP-A) increases local IGF-1 bioactivity by cleaving IGF binding proteins.
Purpose of the Study:
- To investigate the role of PAPP-A in ADPKD pathogenesis.
- To explore PAPP-A as a therapeutic target for ADPKD.
Main Methods:
- Analysis of PAPP-A levels in ADPKD mouse models and human samples.
- Investigating PAPP-A transcriptional regulation via the cAMP/CREB/CBP/p300 pathway.
- Evaluating the therapeutic potential of PAPP-A inhibition using monoclonal antibodies in preclinical ADPKD models.
Main Results:
- PAPP-A was highly induced in the kidneys of ADPKD mice and elevated in human ADPKD cystic fluid and kidneys.
- PAPP-A deficiency ameliorated cyst development in Pkd1RC/RC mice.
- Monoclonal antibody treatment blocking PAPP-A activity reduced ADPKD cyst progression in vivo and ex vivo.
Conclusions:
- The PAPP-A/IGF-1 pathway is crucial for ADPKD cyst growth and expansion.
- Inhibiting PAPP-A's proteolytic activity presents a promising therapeutic strategy for ADPKD.
Abstract:
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic cause of end-stage renal disease (ESRD). The treatment options for ADPKD are limited. We observed an upregulation in several IGF-1 pathway genes in the kidney of Pkd1RC/RC mice, a model of ADPKD. Pregnancy-associated plasma protein A (PAPP-A), a metalloproteinase that cleaves inhibitory IGF binding proteins (IGFBPs), increasing the local bioactivity of IGF-1, was highly induced in the kidney of ADPKD mice. PAPP-A levels were high in cystic fluid and kidneys of humans with ADPKD. Our studies further showed that PAPP-A transcription in ADPKD was mainly regulated through the cAMP/CREB/CBP/p300 pathway. Pappa deficiency effectively inhibited the development of cysts in the Pkd1RC/RC mice. The role of PAPP-A in cystic disease appears to be regulation of the IGF-1 pathway and cellular proliferation in the kidney. Finally, preclinical studies demonstrated that treatment with a monoclonal antibody that blocks the proteolytic activity of PAPP-A against IGFBP4 ameliorated ADPKD cystic disease in vivo in Pkd1RC/RC mice and ex vivo in embryonic kidneys. These data indicated that the PAPP-A/IGF-1 pathway plays an important role in the growth and expansion of cysts in ADPKD. Our findings introduce a therapeutic strategy for ADPKD that involves the inhibition of PAPP-A.
More Related Videos
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Role of Matrix Metalloproteases in Degradation of ECM
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...